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The aqueous solution structure of the full-length recombinant ovine prion
protein PrP25-233, together with that of the N-terminal truncated version
PrP94-233, have been studied using vibrational Raman optical activity
(ROA) and ultraviolet circular dichroism (UVCD). A sharp positive band at
w1315 cmK1 characteristic of poly(L-proline) II (PPII) helix that is present
in the ROA spectrum of the full-length protein is absent from that of the
truncated protein, together with bands characteristic of b-turns. Although
it is not possible similarly to identify PPII helix in the full-length protein
directly from its UVCD spectrum, subtraction of the UVCD spectrum of
PrP94-233 from that of PrP25-233 yields a difference UVCD spectrum also
characteristic of PPII structure and very similar to the UVCD spectrum of
murine PrP25-113. These results provide confirmation that a major
conformational element in the N-terminal region is PPII helix, but in
addition show that the PPII structure is interspersed with b-turns and that
little PPII structure is present in PrP94-233. A principal component analysis
of the ROA data indicates that the a-helix and b-sheet content, located in
the structured C-terminal domain, of the full-length and truncated proteins
are similar. The flexibility imparted by the high PPII content of the N-
terminal domain region may be an essential factor in the function and
possibly also the misfunction of prion proteins.
q 2004 Elsevier Ltd. All rights reserved.
Keywords: ovine prion protein; transmissible spongiform encephalopathy;
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Introduction
Prion proteins are associated with a variety of
neurodegenerative diseases, known as transmiss-
ible spongiform encephalopathies (TSE), character-
ised by the presence of spongiform degeneration
and astrocytic gliosis.1 Despite much effort, an
understanding of some key aspects of TSE disease
remains elusive, such as the existence of an
infectious form along with genetic and sporadic
forms, something that has not been recognised in
any other class of neurodegenerative disease. The
basic current model involves conversion of a
ubiquitous cellular form of the prion protein
(PrPC) into a scrapie (amyloid fibril) form (PrPSc),
the prion protein being both target and infectious
agent. PrPC has a high proportion of a-helical
structure, is soluble in detergents and is susceptible
to proteolysis. Conversely, PrPSc has a high b-sheet
content, is insoluble in detergents and is partially
resistant to proteolysis. Further understanding of
TSE disease requires more detailed knowledge of
the solution structures of prion proteins and the
conformational changes associated with the poss-
ible different transformation pathways of PrPC into
PrPSc that are involved in the infectious, genetic and
sporadic forms.2
After expression and post-translational process-
ing, PrPC has between 208 and 220 amino acid
residues depending on mammalian species, two
N-glycan linkage sites of variable occupancy and a
C-terminal glycosyl-phosphatidylinositol (GPI)
membrane anchor. Structural analysis by Fourier
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transform infrared (FTIR) and ultraviolet circular
dichroism (UVCD) spectroscopy indicated that
PrPC contains w40% a-helix and little b-sheet,
whilst PrPSc contains w30% a-helix and w45%
b-sheet.3,4 Although there have been numerous
NMR studies on the solution structure of PrPC,5
X-ray crystallographic studies have been hampered
by difficulties in crystallising the protein. The NMR
structures of full-length recombinant prion proteins
of different mammalian species all revealed a
structured C-terminal globular domain containing
mainly a-helical sequences in the form of a compact
three-helix bundle, and a long flexibly disordered
N-terminal domain of 80–100 amino acid residues,
which includes a metal ion binding octapeptide
repeat motif.6 Recently, however, the first crystal
structure of a monomeric recombinant prion pro-
tein, namely ovine PrP, has been solved7 and found
to be very similar to the solution NMR structures of
other mammalian species. For crystallisation, only
the folded C-terminal domain 128–233 was present.
This structure of ovine PrP128-233 is represented
pictorially in Figure 1.
An increasing amount of research is focusing on
the contribution of the disordered N-terminal
region to PrPC function. Previously, the role of this
region in the disease process tended to be over-
looked mainly because a long N-terminal segment
of PrPSc is lost on in vitro proteolytic digestion of
PrPSc to the core structure PrP27-30 (meaning a
protein of between 27 kDa and 30 kDa). In addition,
transgenic mice that are devoid of much of the
N-terminal region still support prion replication,8,9
indicating that the N-terminal region is not required
a priori for the conversion process. However,
immunologic studies of PrPSc suggest that the
conformational change that occurs during conver-
sion of PrPC into PrPSc is mostly in the region from
residues w94–149 or perhaps 179 with the major
changes localised largely to a part of the disordered
N-terminal region bounded by residues w94 and
w124,10,11 and Donne et al.12 have suggested that
the N-terminal region could feature in the conver-
sion of PrPC to PrPSc by template-assisted formation
of b-structure. Furthermore, recent evidence
suggests that the presence of the N-terminal region
could play a key role in determining the confor-
mation of PrPSc and in modulating cross-species
disease transmission and TSE pathogenesis.13 Thus,
the impact of the N-terminal region on the structure
of mature length PrP is clearly of considerable
importance in TSE disease.
Many reports of structural characterisation of the
octapeptide repeat region of the N-terminal domain
of PrPSc complexed with copper ions exist, includ-
ing a recent crystal structure of copper complexed
to a pentapeptide derived from the prion N
terminus.14 Conversely, there is scant information
on the structure of this domain in isolation,
primarily because the detailed characterisation of
non-regular peptide sequences in proteins is diffi-
cult using standard solution phase structural
techniques such as NMR and UVCD. However, it
has recently been shown that Raman optical activity
(ROA), which measures vibrational optical activity
by means of a small difference in the intensity of
Raman scattering from chiral molecules in right-
and left-circularly polarised incident laser light,15–18
is able to provide new information about the
structure of disordered sequences in intact proteins
in aqueous solution.19 This work suggests that an
important conformational element in such
sequences is poly(L-proline) II (PPII) helix.
Although originally defined for the conformation
adopted by polymers of L-proline, PPII helix can be
supported by amino acid sequences other than
those based on L-proline and has been recognised as
a common structural motif within loops in the X-ray
crystal structures of many proteins.20 It consists of a
left-handed helix with 3-fold rotational symmetry
in which the f, j angles of the constituent residues
have values aroundK788,C1468, corresponding to
a region of the Ramachandran surface to one side of
the b-region. The extended nature of the PPII helix
precludes intrachain hydrogen bonds, the structure
being stabilised instead by main-chain hydrogen
bonding with water molecules and side-chains.21
PPII helix currently attracts much interest as a
major conformational element of disordered poly-
peptides and unfolded proteins in aqueous sol-
ution.22 PPII structure can be distinguished from
random coil in polypeptides by UVCD,22,23
Figure 1. The tertiary structure of the globular,
C-terminal domain of the ovine prion protein as
determined by X-ray crystallography.7 The structure
was rendered using Molmol and Povray.
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vibrational circular dichroism (VCD),24 FTIR and
Raman25 and ultraviolet Raman,26 but these tech-
niques are less sensitive than ROA to PPII structure
when there are a number of other conformational
elements present as in proteins. Although the lack
of main-chain hydrogen bonding makes NMR
determinations of PPII structure difficult, a recent
NMR study, complemented by UVCD, of a peptide
sequence containing seven alanine residues pro-
vides strong evidence for a predominantly PPII
conformation in aqueous solution.27 A subsequent
ROA study of a similar peptide firmly demonstrated
the ability of ROA to identify PPII structure.28 PPII
helix may be important in the regulatory multiple
weak interactions that are increasingly being recog-
nised as associated with intrinsically unstructured
peptide sequences within proteins.23,29–32 Further-
more, proteins that are completely unfolded in their
native state may contain a large amount of PPII
helix, which imparts a rheomorphic (flowing shape)
character to their structure33 and which appears to
be important for their function.34
The presence of significant amounts of PPII
structure in the N-terminal disordered region of
the prion protein has already been suggested from
UVCD studies of synthetic polypeptides based on
the octarepeat region.35,36 Subsequent UVCD
studies of the N-terminal peptide PrP40-57 showed
that it can also form a PPII structure in aqueous
buffer, with the discovery of 4-hydroxyproline in
recombinant PrP from Chinese hamster ovary cells
and PrPSc from terminally infected mouse brains
providing proof for the formation of PPII helix in
PrP in vivo.37 In addition, NMR measurements of
peptides derived from the octarepeat region of PrP
suggested that certain residues adopt loop and
b-turn structures.38,39
Here, we report an ROA study of the aqueous
solution structures, especially the characterisation
of PPII helix, of recombinant ovine prion protein
residues 25–233, the sequence of which is given in
Figure 2, and the N-terminal truncated protein
comprising residues 94–233, in order to obtain new
information about the fold of these biomolecules.
This information is compared with that derived
from UVCD spectra of the same proteins and a
C-terminally truncated construct.
Results and Discussion
Figure 3 shows the back-scattered Raman and
ROA spectra of ovine PrP25-233 and PrP94-233 in
aqueous solution. Despite the high backgrounds to
the parent Raman spectra of the two samples, ROA
spectra of reasonable quality were obtained by
summing the spectra acquired in several different
measurement runs. An account of most of the
ROA assignments given in what follows can be
found.19,40,41
PPII helix
A prominent feature in the ROA spectrum of
PrP25-233 (Figure 3, top) is the narrow positive band
observed at w1315 cmK1 within the extended
amide III region (w1230–1350 cmK1) where normal
vibrational modes made up of various combi-
nations of the in-plane N–H deformation (in-
phase), the C–N stretch and CaKH deformations
Figure 2. The amino acid sequence of the ovine prion
protein. The initial 24 amino acid residues and final 23
amino acid residues comprise the N-terminal and
C-terminal signal peptides, respectively. The full-length
prion protein starts at lysine 25 (in bold); the N-terminally
truncated protein starts at glycine 94 (bold and italic).
Both constructs end at the mature C terminus, alanine
233.
Figure 3. Back-scattered Raman (IRCIL) and ROA
(IRKIL) spectra in sodium acetate buffer (pH 5.5), of
ovine PrP25-233 (top pair) and PrP94-233 (bottom pair).
The high fluorescence backgrounds have been sub-
tracted from the Raman spectra.
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occur. A similar positive band at w1319 cmK1
dominates the ROA spectra of disordered poly
(L-lysine) and poly(L-glutamic acid).19 Since these
disordered polypeptides are thought to contain
substantial amounts of the PPII-helical confor-
mation, perhaps in the form of short segments
interspersed with residues having other confor-
mations,22 this ROA band has been assigned to a
vibrational mode of the PPII helix. Similar positive
bands are seen in this region in the ROA spectra of
some b-sheet proteins where they have been
assigned to PPII-helical elements.16,19 This assign-
ment has been reinforced recently by an ROA
study of the aqueous solution structures of a
series of alanine oligopeptides, including
AcOOAAAAAAAOO-NH2, the ROA spectrum of
which is dominated by a positive ROA band at
w1319 cmK1.28 This peptide is similar to the one
shown by Shi et al.27 to adopt a predominantly PPII
conformation. PrP25-233 therefore appears to contain
a significant number of residues in the PPII
conformation. Since the positive w1315 cmK1
band is absent from the ROA spectrum of PrP94-233
(Figure 3, bottom), we deduce that most of the PPII
sequences are located in the N-terminal 23–89
fragment. Also missing from the PrP94-233 ROA
spectrum are the negative and positive bands at
w1257 cmK1 and 1296 cmK1, respectively, assigned
to b-turns,40 from which we deduce that the 23–89
fragment also contains b-turns. These results are
consistent with the previous suggestions of both
PPII and b-turns in the N-terminal region.35–39
The UVCD spectra of ovine PrP25-233 and PrP94-233
are displayed in Figure 4(a). Both show character-
istic minima at w222 nm and 208 nm, indicating a
predominance of a-helix in the structures. Although
the UVCD spectra are qualitatively very similar,
they are quantitatively different. These differences
arise either from differences in the folded domains
of each protein or from the presence of the
N-terminal region in PrP25-233. Since NMR determi-
nations of PrP globular structures indicated only
subtle differences in these regions when the
N-terminal region was incorporated, we believe
that the differences in the UVCD spectra reflect the
contributions made to the spectra by the N-terminal
region.
Subtraction of the UVCD spectrum of PrP94-233
from that of PrP25-233 yields a difference spectrum
(Figure 4(b)) with a strong negative minimum at
w195 nm and a weak positive maximum atw220–
230 nm characteristic of PPII-helix,22,23 which, in
agreement with the conclusions from the ROA data,
may be ascribed to PPII structure in the 25–93
fragment. This spectrum is similar to those pre-
viously determined for the octapeptide repeat
region35,36 and for a peptide spanning residues
40–57.37 To further confirm the similarities between
these spectra, in Figure 4(b) we also present the
UVCD spectrum of a polypeptide derived from
murine PrP spanning residues 25–113, which is very
similar to the subtracted spectrum and to previous
spectra of N-terminal sequences. It also has a
maximum at 220–230 nm and a minimum at
w200 nm characteristic of PPII helix. Unfortunately,
this polypeptide was only sparingly soluble in
physiological buffers and was therefore not amen-
able to ROA analysis.
a-Helix and b-sheet: principal
component analysis
Useful ROA signatures of a-helix include positive
extended amide III bands atw1300–1310 cmK1 and
w1340 cmK1 characteristic of unhydrated and
hydrated versions, respectively, and an amide I
couplet centred at w1650 cmK1 that is negative at
low wave number and positive at high.41 Useful
b-sheet ROA signatures include negative bands at
w1220 cmK1 and 1245 cmK1 possibly associated
with hydrated and unhydrated variants, respect-
ively, and a similar amide I ROA couplet to that
generated by a-helix but shifted by w10 cmK1 to
higher wave number.40
We are developing a pattern recognition pro-
gram, based on principal component analysis
(PCA), to identify protein structural types from
ROA band patterns.40 From the ROA spectral data,
Figure 4. (a) UVCD spectra of recombinant ovine
PrP25-233 (triangles) and PrP94-233 (diamonds). (b) Sub-
tracted UVCD spectrum of PrP25-233–PrP94-233 (squares)
together with the UVCD spectrum of murine PrP25-113
(circles). The units of the molar ellipticity [q] are
degrees cm2/mol.
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PCA calculates a set of sub-spectra that serve as
basis functions, the algebraic combination of which
with appropriate expansion coefficients can be used
to reconstruct any member of the original set of
experimental ROA spectra. Figure 5 shows a plot of
the coefficients for our current set of 80 polypeptide,
protein and virus ROA spectra for the two most
important basis functions. This map provides a
two-dimensional representation of the structural
relationships among the members of the set. The
protein positions are colour-coded with respect to
the seven different structural types listed in the
Figure and which provide a useful initial classifi-
cation that will be refined in later work to give
quantitative estimates of structural elements such
as helix, sheet, loops and turns. The spectra separate
into clusters corresponding to different dominant
types of protein structural elements, with increasing
a-helix content to the left, increasing b-sheet content
to the right, and increasing disordered or irregular
structure from bottom to top. PrP25-233 and PrP94-233
lie close together near the centre of the alpha beta
region, which reinforces the impression from visual
inspection of their ROA spectra of a significant
amount of b-structure in both in addition to the
expected a-helix. This also suggests little difference
in the amounts of a-helix and b-sheet in the full-
length and truncated proteins. However, PrP94-233
lies below PrP25-233, consistent with the absence of
the disordered N-terminal region. Disordered
poly(L-lysine), poly(L-glutamic acid) and the
AcOOAAAAAAAOO-NH2 peptide lie towards
the top of the Figure.
The similar amount of a-helix in PrP25-233 and
PrP94-233 revealed by ROA is consistent with the
NMR solution structures, which indicate almost
identical amounts of a-helix in full-length and
truncated prion proteins (for example, PDB struc-
tures 1qlz and 1qml for the resolved sequence 128–
231 in human PrP25-233 and PrP94-233 contain 51.9%
and 51.0% a-helix, respectively). However, our
ROA data reflect a higher b-sheet content than
that expected from the solution NMR structures
(w3–9% in sequence 125–228). This may be due to
oligomerisation at the high concentrations of ovine
PrP25-233 and PrP94-233 used (w40 mg/ml). Analyti-
cal ultracentrifugation showed our samples to be
monomeric at w5 mg/ml (data not shown) but we
anticipate the formation of dimers and oligomers at
higher concentrations.
On the basis of recent work on model b-sheet
polypeptides and proteins,40 the positive ROA band
at w1557 cmK1 (amide II) and negative ROA band
at w1616 cmK1 (amide I) in the spectra of PrP25-233
and PrP94-233 suggest the presence of multi-
stranded b-sheet that is more flat and uniform
than that found in typical b-sheet proteins. Again
this may reflect some oligomerisation.
Implications for prion function and
aggregation
Sequence analysis revealed that the N-terminal
region of PrPC is highly conserved between
species,42,43 which suggests that it has an important
      
      
      
Figure 5. Plot of the PCA coefficients for the two most important basis functions for a set of 80 polypeptide, protein and
virus ROA spectra. More complete definitions of the structural types are: all alpha,Ow60% a-helix with little or no other
secondary structure; mainly alpha, Ow35% a-helix and a small amount of b-sheet (w5–15%); alpha beta, similar
significant amounts of a-helix and b-sheet; mainly beta,Ow35% b-sheet and a small amount of a-helix (w5–15%); all
beta,Ow45% b-sheet with little or no other secondary structure; mainly disordered/irregular, little secondary structure;
all disordered/irregular, no secondary structure. dPLL, dPLG and OAO denote disordered poly(L-lysine), disordered
poly(L-glutamic acid) and AcOOAAAAAAAOO-NH2, respectively.
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structural and functional role.44 The results of some
studies indicate that this functional role involves
copper metabolism:6 four Cu2C ions bind to the
protein in the highly conserved group of octapep-
tide repeats, having the consensus sequence
PHGGGWGQ and spanning residues 54–95 in the
ovine prion protein, with a fifth taken up in the
flexible region between the octarepeats and the
globular C-terminal region.45 Presumably the rheo-
morphic character of the PPII-rich N-terminal
region of the apoprotein, together with the ability
of the four glycine residues within each octarepeat
to support turns and extended structure as well as
PPII, enables the appropriate sequences to readily
adapt to the fixed Cu(II)-bound conformation of the
holoprotein. This conformational adaptability may
also be important in binding of PrP to other ligands
within the intra- or extra-cellular environments.
Various binding partners for the N-terminal region
of PrP have been suggested, including polya-
nions,46 the laminin receptor47 and nucleic acids.48
It is therefore likely that an extended, rather flexible
structure in this region is important in promoting
binding and facilitating molecular interactions.
An ROA study revealed that PPII helix is formed
at the expense of hydrated a-helix in the prefibrillar
amyloidogenic intermediate of human lysozyme,
which prompted the suggestion that PPII helix
could be a critical conformational element in some
amyloid diseases.49 Elimination of water molecules
between extended PPII chains having hydrated
backbone C]O and N–H groups to form b-sheet
hydrogen bonds is a favourable thermodynamic
process.50 Since PPII chains are close in confor-
mation to b-strands, they would be expected to
readily undergo this type of aggregation with each
other and with established b-sheet. A more recent
study using conventional techniques has corro-
borated this idea, but without explicitly identifying
the extended polypeptide chains as PPII-type
structure.51 A subsequent ROA study of the brain
proteins a-synuclein and tau, which have a pro-
pensity to form the fibrils associated with Parkin-
son’s and Alzheimer’s disease, respectively,
revealed that these natively unfolded proteins
consist largely of PPII helical sequences.33 However,
although disorder of the PPII type may be essential
for the formation of regular fibrils, the presence of a
large amount of PPII structure does not necessarily
impart a fibrillogenic character since not all PPII-
rich non-regular protein structures form amyloid
fibrils. For example, the casein milk proteins and the
brain proteins b- and g-synuclein show little
propensity for amyloid fibril formation and are
not associated with disease, yet their natively
unfolded structures are based largely on PPII
sequences as in a-synuclein, which is highly
amyloidogenic.33 A more complete understanding
of the fibrillogenic propensity of a particular
sequence, PPII or otherwise, requires knowledge
of the various physicochemical properties of the
constituent residues.52 In particular, a combination
of high net charge and low mean hydrophobicity
has been shown to be an important prerequisite for
protein sequences to remain natively unfolded.34,53
The potential importance of PPII in amyloid
disease has been reinforced by recent demon-
strations of the presence of significant amounts of
this conformation in the Alzheimer amyloid pep-
tide Ab(12–28) by UVCD54 and in Ab(1–28) by FTIR
and Raman.55 The latter study also identified the
presence of b-strand.
There have been some recent attempts to use
spectroscopic data to quantify the propensities
of different residues to adopt the PPII confor-
mation.31,56–58 The 25–93 sequence of the disordered
N-terminal region of PrPC has a high proportion of
proline (ten) and glycine (31) residues, many of
which occur in the metal-binding group of octa-
repeats. It appears that glycine is quite favourable
for PPII formation, perhaps due to backbone
solvation,56 so that, together with the very high
PPII propensity of proline itself, the 25–93 sequence
is expected to have a high average PPII propensity.
The physicochemical properties of the constitu-
ent residues of the disordered N-terminal region are
highly relevant to the prion problem. Since PrPSc
formation, and prion propagation, are possible with
deletions in PrPC up to residuew110, these residues
are evidently not playing a critical role in PrP
misfolding. In addition, since the protease-resistant
core structure of PrPSc formed from full-length PrPC
contains only residues w90–233, most of the
N-terminal sequence appears not to participate in
the compact folded domain of PrPSc. It therefore
appears that, despite the high PPII content revealed
by the present study, the 25–93 sequence of the
disordered N-terminal region of PrPC is not
intrinsically fibrillogenic. Due to the presence of
four positively charged residues in the extreme
N-terminal sequence KKRPKP, the N-terminal end
carries a high net charge and also has a low mean
hydrophobicity. Although the mean hydrophobi-
city of the rest of the 25–93 sequence is only average,
w59% of the sequence is made up of proline and
glycine residues, which have very low b-sheet
forming propensities.59 The 25–93 sequence of the
disordered N-terminal region therefore appears to
be well protected against association into b-sheet
structures.
Comparison of the solution NMR structures of
full-length and truncated prion proteins revealed
that the N-terminal region has a small but signifi-
cant stabilising influence on certain sequences of the
structured C-terminal domain. The first indication
of this was the detection of a stabilisation of helical
structure associated with residues 190–196 within
helix 2 of the hamster prion protein that was
suggested to arise from transient tertiary inter-
actions between the N-terminal residues and helix 2
residues.12 Subsequent studies of human prion
protein revealed a similar stabilisation of this
segment of helix 2, but also revealed some
stabilisation in residues 222–22960 and 219–22561
within helix 3, with similar observations for the
bovine prion protein.62 However, the implied
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increase of helix population amounts only to a few
percent,60 as confirmed by our ROA results. So
although not directly participating in the b-fibril
formation responsible for prion disease, it appears
from these NMR studies that there is scope for the
disordered N-terminal region to modulate the
fibrillogenesis itself, together with the infectivity
and species barriers that characterise prion disease.
Certainly, this was born out in recent investigations
of cross-species disease transmission in vivo and
in vitro.13
Conclusions
ROA has revealed that a major conformational
element in the “disordered” N-terminal region of
the full-length ovine prion protein PrP25-233 is PPII
helix, which was confirmed by UVCD, and that
some b-turns are also present. ROA further revealed
that little PPII structure is present in the truncated
protein PrP94-233 and that the amounts of a-helix in
the full-length and truncated proteins are very
similar. The presence of a large amount of PPII
structure in the N-terminal region is consistent with
the flexibility required for its ability to bind metal
ions and for its apparent ability to modulate
properties of the full-length protein via interactions
with the structured C-terminal region. Changes in
environmental factors, or of the physicochemical
properties of critical residues associated with
genetic variants, could readily modify subtle
characteristics such as fibrillogenic propensity of
particular sequences within the N-terminal region
itself or within regions of the C-terminal domain
that interact with this region. Hence, the PPII-rich
character of the N-terminal region appears to be an
essential factor in the function, and possibly a
modulating factor in the misfunction, of prion
proteins.
Materials and Methods
Materials
Recombinant prion proteins were produced as
described.63,64 Briefly, PrP proteins were expressed from
the pTrc plasmid (Quiagen) either without (PrP25-233) or
with (PrP94-233) the hexHis tag in Escherichia coli cells.
Protein production was induced by the addition of IPTG
and cells were harvested by centrifugation. Cells were
lysed using lysozyme and inclusion bodies harvested by
centrifugation after removal of DNA by treatment with
sodium deoxycholate and DNase. Protein from inclusion
bodies was solubilised in 8 M urea and PrP purifed by
immobilised metal ion affinity chromatography followed
by cation exchange chromatography. The single disul-
phide bond was remade by incubation with fivefold
molar excess of copper ions followed by extensive
dialysis against 50 mM sodium acetate to refold the
protein. Final fractions were checked by SDS-PAGE,
UVCD and electrospray mass spectrometry (ESMS).
Concentrations were determined by UV absorbance.
To produce fractions of sufficient concentration for
ROA spectroscopy, protein was concentrated in filtration
concentration devices of progressively smaller size
(centriprep, centricon, microcon; Amicon). Final concen-
tration was done by removal of solvent under vacuum.
The fidelity of the protein was checked after concentration
by removal of a 1 ml aliquot, dilution and analysis by
UVCD and ESMS.
DNA encoding the murine PrP sequence 25–113 was
cloned from a template of the full-length protein and
inserted into the pTrc expression plasmid (Quiagen).
Transformed E. coli were used for expression of the
protein, which was isolated as described above. Yields
of this polypeptide were poor and the final fraction was
only sparingly soluble in 50 mM sodium acetate (pH 5.5).
ROA spectroscopy
The instrument used for the Raman and ROA measure-
ments has a back-scattering configuration, which is
essential for ROA studies of aqueous solutions of
biopolymers, and employs a single-grating spectrograph
fitted with a back-thinned CCD camera as detector and an
edge filter to block the Rayleigh line.65 ROA is measured
by synchronising the Raman spectral acquisition with an
electro-optic modulator to switch the polarisation state of
the incident argon-ion laser beam between right and left
circular at a suitable rate. The spectra are displayed in
analog-to-digital counter units as a function of the Stokes
wave number shift with respect to the exciting laser wave
number. The ROA spectra are presented as circular
intensity differences IRKIL and the parent Raman spectra
as circular intensity sums IRCIL, where IR and IL are the
Raman-scattered intensities in right- and left-circularly
polarised incident light, respectively.
The PrP25-233 and PrP94-233 solutions were studied at
concentrations w40 mg/ml in w50 mM acetate buffer
(pH 5.5), at ambient temperature (w20 8C). The solutions
were filtered through 0.22 mm Millipore filters into quartz
microfluorescence cells, which were centrifuged gently
prior to mounting in the ROA instrument. Residual
visible fluorescence from traces of impurities, which can
give large backgrounds in Raman spectra, was quenched
by leaving the samples to equilibrate in the laser beam for
a few hours before acquiring ROA data. The experimental
conditions were as follows: laser wavelength, 514.5 nm;
laser power at the sample,w700 mW; spectral resolution,
w10 cmK1; acquisition time, w50 hours in total for the
prion proteins.
UVCD spectroscopy
The UVCD spectra were recorded by use of a Jasco
J-710 spectropolarimeter. All samples were dissolved in
sodium acetate buffer (pH 5.5). Spectra of PrP25-233
(0.62 mg/ml) and PrP94-233 (0.64 mg/ml) were recorded
in a cell of path length 0.01 cm. The spectrum of murine
PrP23-109 (0.03 mg/ml) was recorded in a cell of path
length 0.2 cm. The spectra were averaged over three
individual spectra, each being the sum of at least 20 scans.
Concentrations were determined by UV absorbance at
280 nm by use of a Beckman DU650 spectrophotometer.
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